Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Journal of Clinical Medicine|February 11, 2023
Proposed Implementation of a Patient-Centered Self-Assessment Tool for Patients with Neuroendocrine Tumors among Academic and Community Practice Sites: The City of Hope ModelChristiana Joy Crook, Lisa Yen, Kathleen Ta, et al.
Liver Cancer|January 2, 2023
Atezolizumab plus Bevacizumab versus Sorafenib for Unresectable Hepatocellular Carcinoma: Results from Older Adults Enrolled in the IMbrave150 Randomized Clinical TrialDaneng Li, Han Chong Toh, Philippe Merle, et al.
Surgery|November 19, 2018
Prognostic significance of Chromogranin A in small pancreatic neuroendocrine tumorsMustafa Raoof, Zeljka Jutric, Laleh G Melstrom, et al.
Frontiers in Oncology|September 2, 2025
Multi-analyte liquid biopsy approaches for early detection of esophageal cancer: the expanding role of ctDNADerek Tai, Kareem Latif, Pranati Shah, et al.
Annals of Surgery|May 11, 2018
Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival With or Without Liver TreatmentAaron Lewis, Mustafa Raoof, Philip H G Ituarte, et al.
Future Oncology (London, England)|March 13, 2023
A multicenter, phase Ib/II, open-label study of tivozanib with durvalumab in advanced hepatocellular carcinoma (DEDUCTIVE)Sharmeen Mahmood, Daneng Li, Arielle Lee, et al.
Journal of Clinical Medicine|September 14, 2024
Liver Resection for Gastroenteropancreatic Neuroendocrine Tumors with Extrahepatic DiseaseKelly M Mahuron, Kristen E Limbach, Matthew C Hernandez, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 22, 2020
Preclinical PET Imaging of NTSR-1-Positive Tumors with 64Cu- and 68Ga-DOTA-Neurotensin Analogs and Therapy with an 225Ac-DOTA-Neurotensin AnalogDaneng Li, Megan Minnix, Rebecca Allen, et al.
Neuroendocrinology|August 12, 2019
Lymphovascular Invasion Predicts Lymph Node Involvement in Small Pancreatic Neuroendocrine TumorsAndrew M Blakely, Kelly J Lafaro, Daneng Li, et al.
Surgery|February 27, 2021
Does surgery provide a survival advantage in non-disseminated poorly differentiated gastroenteropancreatic neuroendocrine neoplasms?Lucas W Thornblade, Susanne G Warner, Laleh Melstrom, et al.
Pageof 11